Amarin Corp Plcuk (AMRN) Other Non-Current Liabilities (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Other Non-Current Liabilities of $11.1 million for Q1 2026, down 4.47% year-over-year from $11.6 million in Q1 2025, and up 1.52% quarter-over-quarter from $11.0 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Other Non-Current Liabilities data on file, last reported at $11.1 million in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $11.1 million, down 4.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.1 million (down 4.47% YoY), and the FY2025 annual result was $11.0 million, down 4.75% from the prior year.
  • Other Non-Current Liabilities advanced to $11.1 million in Q1 2026 per AMRN's latest filing, from $11.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $12.0 million in Q3 2025 and troughed at $7.2 million in Q2 2023.
  • A 5-year average of $9.5 million and a median of $9.3 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities surged 81.25% in 2022, then slipped 25.0% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $8.2 million in 2022, then climbed by 10.47% to $9.1 million in 2023, then climbed by 26.89% to $11.5 million in 2024, then declined by 4.75% to $11.0 million in 2025, then grew by 1.52% to $11.1 million in 2026.
  • Business Quant data shows AMRN's Other Non-Current Liabilities at $11.1 million in Q1 2026, $11.0 million in Q4 2025, and $12.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.12 Mn
Dec 31, 2025 10.96 Mn
Sep 30, 2025 11.96 Mn
Jun 30, 2025 11.92 Mn
Mar 31, 2025 11.64 Mn
Dec 31, 2024 11.50 Mn
Sep 30, 2024 9.47 Mn
Jun 30, 2024 9.34 Mn
Mar 31, 2024 9.20 Mn
Dec 31, 2023 9.06 Mn
Sep 30, 2023 7.27 Mn
Jun 30, 2023 7.16 Mn
Mar 31, 2023 8.61 Mn
Dec 31, 2022 8.21 Mn
Sep 30, 2022 9.70 Mn
Jun 30, 2022 7.64 Mn
Mar 31, 2022 7.49 Mn
Dec 31, 2021 7.65 Mn
Sep 30, 2021 5.35 Mn
Jun 30, 2021 5.53 Mn